NCT07270991
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07270991
Title Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma (FRUQUITAS)
Acronym FRUQUITAS
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Federation Francophone de Cancerologie Digestive
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | DEU


No variant requirements are available.